Enables knowledge workers to extract structured meaning from healthcare data with AI‑driven copilot assistants for smarter care delivery.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Autonomize AI develops an AI-powered platform designed to organize, contextualize, and summarize unstructured healthcare data, significantly easing administrative workflows for medical professionals. It deploys specialized “copilots” that transform raw clinical information into structured insights, enabling more efficient decision-making and improving the overall quality of care.
Autonomize AI Funding
Sign up to gain insights into Autonomize AI funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series A | May 28, 2025 | 750K | ||
| Series A | May 28, 2025 | 25M | ||
| Series A | May 28, 2025 | 3M | ||
| Series Seed | Mar 27, 2023 | 525K | ||
| Series Seed | Mar 27, 2023 | 3M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Autonomize AI Management Team
Investors
Capital Factory
Tau Ventures
The Next Practices Group
ATX Venture Partners
Loop Ventures
Valtruis
Asset Management Ventures
Cigna Ventures
Autonomize AI Valuations & Financials
View real-time NPM data on Autonomize AI stock including daily Autonomize AI stock price estimates, valuation history, and historical share price information. Access Autonomize AI financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Autonomize AI pricing across six independent market signals. Looking for private company due diligence data sources on Autonomize AI? Get in touch to learn more.
Similar Companies
like Autonomize AI
Curology
Healthcare & Life Sciences
Offers personalized prescription skin care medications delivered directly to you.
Cedar
Healthcare & Life Sciences
The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.
Resilience
Healthcare & Life Sciences
Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.
Cerebral
Healthcare & Life Sciences
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
Devoted Health
Healthcare & Life Sciences
Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.
Ro
Healthcare & Life Sciences
Healthcare technology for a patient-centric healthcare system.
Cityblock
Healthcare & Life Sciences
Tech-driven care provider for communities with complex needs.
Elligo Health Research
Healthcare & Life Sciences
Connects healthcare sites, sponsors, and patients to streamline clinical trial access through technology and data-driven solutions.
FAQ
We have answers
Autonomize AI stock does not trade on public stock exchanges. Autonomize AI stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Autonomize AI stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Autonomize AI Stock does not trade on public stock exchanges. In order to sell Autonomize AI shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Autonomize AI does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Autonomize AI share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Autonomize AI stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Autonomize AI stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Autonomize AI stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Autonomize AI is a private company and has not had an IPO. There is currently no Autonomize AI IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Autonomize AI IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
